Preclinical trial of the multi-targeted lenvatinib in combination with cellular immunotherapy for treatment of renal cell carcinoma.
about
Preclinical trial of the multi-targeted lenvatinib in combination with cellular immunotherapy for treatment of renal cell carcinoma.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Preclinical trial of the multi ...... tment of renal cell carcinoma.
@en
type
label
Preclinical trial of the multi ...... tment of renal cell carcinoma.
@en
prefLabel
Preclinical trial of the multi ...... tment of renal cell carcinoma.
@en
P2093
P2860
P356
P1476
Preclinical trial of the multi ...... tment of renal cell carcinoma.
@en
P2093
Baixin Shen
Chengkuan Cai
Haoliang Xue
Jingyuan Tang
Liucheng Ding
Yinchao Ma
Yunpeng Shao
Zhengsen Chen
Zhongqing Wei
P2860
P304
P356
10.3892/ETM.2017.4858
P577
2017-07-31T00:00:00Z